قالب وردپرس درنا توس
Home / Health / Trump’s vaccine promise comes true

Trump’s vaccine promise comes true



President Trump has optimistically promised that the vaccine developed for COVID-19 will be ready before the election or the end of the year, which seems increasingly difficult to deliver.

In an interview with the Journal of the American Medical Association on Wednesday, Dr. Anthony Fauci adjusted the timetable for when government authorities will prepare the vaccine.

“It may be January, it may be later. We don’t know,” said Fauci, the chief expert on infectious diseases at the President’s Coronavirus Task Force.

In early October, shortly after receiving treatment for his COVID-19 infection at the Walter Reed Medical Center, Trump repeatedly reiterated during his campaign that “the vaccine will come soon.” However, when the drug maker Pfizer announced on October 16 that it would postpone its application for emergency authorization to the U.S. Food and Drug Administration (FDA) to distribute the vaccine it was developing, Trump eased his statement, saying The vaccine will be launched in “a few weeks.”

STAT reported that during the company’s earnings conference call on Tuesday, Pfizer revealed that so far, it has been unable to analyze phase III clinical trials to determine whether its vaccine is safe and effective. Without this analysis, the FDA will not grant emergency use authorization.

“I can tell you that apart from the science and data related to these clinical trials, our decision at the FDA will not be based on any other criteria,” FDA director Stephen Hahn told CBS News in September.

A few days ago, he was responding to the President’s accusations that the FDA had been adopted by “deep countries”, which delayed the release of the vaccine and thus compromised his chances of reelection.

The conflict prompted Alex Azar, the Secretary of Health and Human Services and Trump’s loyal supporter, to seek to replace the FDA director, according to Politico.

But Trump’s claim that a vaccine can be ready on November 3 is always impossible. Although “speed of operation” has made significant initial progress in vaccine production, reality has emerged in recent weeks, as manufacturers such as AstraZeneca and Johnson & Johnson were forced to suspend vaccine trials after participants became ill.

President Trump campaigns at Laughlin/Bullhead International Airport in Bullhead, Arizona, October 28, 2020 (Brendan Smialowski/AFP via Getty Images)
President Trump campaigns at Laughlin/Bullhead International Airport in Bullhead, Arizona, October 28, 2020 (Brendan Smialowski/AFP via Getty Images)

This setback is common in vaccine development and does not necessarily mean that the tested compound causes disease, but researchers must investigate to rule out this disease.

Health experts have always known that this vaccine is highly likely to be made available to the public before the end of the year. The director of the Centers for Disease Control and Prevention, Robert Redfield, testified to Congress in mid-September that the vaccine will not be widely available until late spring or early summer next year.

“If you ask me when the American public can use it so that we can start using the vaccine to restore our normal lives, I think we may be studying the end of the second quarter, the third quarter, Redfield said:” Lampe believes that correction is necessary.

“I think he made a mistake when he said that,” Trump said at a White House press conference the next day. “This is just incorrect information. I called him and he didn’t tell me. I think he may be confused about the news-maybe he was wrong.”

Trump’s optimism is that he plans to recruit the US military to distribute vaccines, which in turn assumes that safe and effective products are available.

Trump said in the final presidential debate: “We have prepared the vaccine,” “It will be announced in a few weeks and will be delivered. We have “Operation Warp Speed”, the army, The vaccine will be distributed.”

But Trump’s own military officials may not have participated in the plan.

In an interview at the end of September, Charles Pritchard, a spokesman for the Department of Defense, said: “Our best military assessment is that the United States has sufficient commercial transportation capacity to fully support the distribution of vaccines.” Departments or personnel do not need to invest a lot of money to support the distribution of vaccines across the country.”

To date, COVID-19 has killed more than 228,000 Americans and infected more than 8.9 people in the United States. The pandemic is getting worse, and new cases nationwide have increased by 41% in the past 14 days. In the past 24 hours alone, the United States has reported 81,457 new cases and 1,016 deaths from COVID-19.

Phase III vaccine trials are underway, and it is conceivable that the company can seek emergency use authorization from the FDA within a few weeks after the election. Even so, this does not mean that the vaccine will be approved before the end of this year, or, even so, most Americans can use it until after the “dark winter” Trump opponent Joe Biden. future.

_____

Read more information from Yahoo News:




Source link